Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)

NACompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

December 20, 2016

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Mitral Valve Prolapse
Interventions
DEVICE

Cardiac MRI

"Group-A patients, with mitral valve prolapse but no mitral regurgitation, will undergo specifically for research purposes a cardiac MRI, 24-hour external loop recording and exercise ECG on top of regular echocardiography evaluation.~Realization of these examinations will be performed according to recommendations for patients with mitral regurgitation (groups B, C and D)"

Trial Locations (1)

54511

Nancy University Hospital, Department of Cardiology, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT02879825 - Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse) | Biotech Hunter | Biotech Hunter